Cargando…

Blood transfusion during radical chemo-radiotherapy does not reduce tumour hypoxia in squamous cell cancer of the head and neck

BACKGROUND: Patients with head and neck squamous cell carcinoma (HNSCC) undergoing radical chemo-radiation (CRT) frequently receive transfusion with packed red cells (PRCT) during radiotherapy on the basis that PRCT increases tumour oxygenation and overcomes hypoxia-induced radio-resistance. This is...

Descripción completa

Detalles Bibliográficos
Autores principales: Welsh, Liam, Panek, Rafal, Riddell, Angela, Wong, Kee, Leach, Martin O, Tavassoli, Mahvash, Rahman, Durdana, Schmidt, Maria, Hurley, Tara, Grove, Lorna, Richards, Thomas, Koh, Dow-Mu, Nutting, Christopher, Harrington, Kevin, Newbold, Kate, Bhide, Shreerang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5220150/
https://www.ncbi.nlm.nih.gov/pubmed/27884018
http://dx.doi.org/10.1038/bjc.2016.386
_version_ 1782492573098573824
author Welsh, Liam
Panek, Rafal
Riddell, Angela
Wong, Kee
Leach, Martin O
Tavassoli, Mahvash
Rahman, Durdana
Schmidt, Maria
Hurley, Tara
Grove, Lorna
Richards, Thomas
Koh, Dow-Mu
Nutting, Christopher
Harrington, Kevin
Newbold, Kate
Bhide, Shreerang
author_facet Welsh, Liam
Panek, Rafal
Riddell, Angela
Wong, Kee
Leach, Martin O
Tavassoli, Mahvash
Rahman, Durdana
Schmidt, Maria
Hurley, Tara
Grove, Lorna
Richards, Thomas
Koh, Dow-Mu
Nutting, Christopher
Harrington, Kevin
Newbold, Kate
Bhide, Shreerang
author_sort Welsh, Liam
collection PubMed
description BACKGROUND: Patients with head and neck squamous cell carcinoma (HNSCC) undergoing radical chemo-radiation (CRT) frequently receive transfusion with packed red cells (PRCT) during radiotherapy on the basis that PRCT increases tumour oxygenation and overcomes hypoxia-induced radio-resistance. This is likely to be a significant oversimplification given the fact that tumour hypoxia is the result of several intrinsic and extrinsic factors, including many that are not directly related to serum haemoglobin (Hb). Therefore, we have studied the effect of PRCT on tumour oxygenation in a prospective cohort of patients who developed low Hb during radical CRT for HNSCC. METHODS: This was a prospective study of 20 patients with HNSCC receiving radical CRT undergoing PRCT for Hb<11.5 g dl(−1). Patients underwent pretransfusion and posttransfusion intrinsic susceptibility-weighted (SWI) MRI and dynamic contrast-enhanced (DCE) MRI. Blood samples were obtained at the time of MRI scanning and two further time points for measuring Hb and a panel of serum cytokine markers of tumour hypoxia. 3D T(2)* and K(trans) maps were calculated from the MRI data for primary tumours and cervical lymph node metastases. RESULTS: PRCT produced no change (11 patients) or reduced (1 patient) T(2)* (tumour oxygenation) in 12 of the 16 (75%) evaluable primary tumours. Three of the four patients with improved tumour oxygenation progressed or had partial response following treatment completion. There were variable changes in K(trans) (tumour perfusion or vessel permeability) following PRCT that were of small magnitude for most tumours. Pre- and Post-PRCT levels of measured cytokines were not significantly different. CONCLUSIONS: This study suggests that PRCT during radical CRT for HNSCC does not improve tumour oxygenation. Therefore, oncologists should consider changing practice according to NICE and American Association of Blood Banks guidelines on PRCT for anaemia.
format Online
Article
Text
id pubmed-5220150
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-52201502018-01-03 Blood transfusion during radical chemo-radiotherapy does not reduce tumour hypoxia in squamous cell cancer of the head and neck Welsh, Liam Panek, Rafal Riddell, Angela Wong, Kee Leach, Martin O Tavassoli, Mahvash Rahman, Durdana Schmidt, Maria Hurley, Tara Grove, Lorna Richards, Thomas Koh, Dow-Mu Nutting, Christopher Harrington, Kevin Newbold, Kate Bhide, Shreerang Br J Cancer Clinical Study BACKGROUND: Patients with head and neck squamous cell carcinoma (HNSCC) undergoing radical chemo-radiation (CRT) frequently receive transfusion with packed red cells (PRCT) during radiotherapy on the basis that PRCT increases tumour oxygenation and overcomes hypoxia-induced radio-resistance. This is likely to be a significant oversimplification given the fact that tumour hypoxia is the result of several intrinsic and extrinsic factors, including many that are not directly related to serum haemoglobin (Hb). Therefore, we have studied the effect of PRCT on tumour oxygenation in a prospective cohort of patients who developed low Hb during radical CRT for HNSCC. METHODS: This was a prospective study of 20 patients with HNSCC receiving radical CRT undergoing PRCT for Hb<11.5 g dl(−1). Patients underwent pretransfusion and posttransfusion intrinsic susceptibility-weighted (SWI) MRI and dynamic contrast-enhanced (DCE) MRI. Blood samples were obtained at the time of MRI scanning and two further time points for measuring Hb and a panel of serum cytokine markers of tumour hypoxia. 3D T(2)* and K(trans) maps were calculated from the MRI data for primary tumours and cervical lymph node metastases. RESULTS: PRCT produced no change (11 patients) or reduced (1 patient) T(2)* (tumour oxygenation) in 12 of the 16 (75%) evaluable primary tumours. Three of the four patients with improved tumour oxygenation progressed or had partial response following treatment completion. There were variable changes in K(trans) (tumour perfusion or vessel permeability) following PRCT that were of small magnitude for most tumours. Pre- and Post-PRCT levels of measured cytokines were not significantly different. CONCLUSIONS: This study suggests that PRCT during radical CRT for HNSCC does not improve tumour oxygenation. Therefore, oncologists should consider changing practice according to NICE and American Association of Blood Banks guidelines on PRCT for anaemia. Nature Publishing Group 2017-01-03 2016-11-24 /pmc/articles/PMC5220150/ /pubmed/27884018 http://dx.doi.org/10.1038/bjc.2016.386 Text en Copyright © 2016 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/4.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/
spellingShingle Clinical Study
Welsh, Liam
Panek, Rafal
Riddell, Angela
Wong, Kee
Leach, Martin O
Tavassoli, Mahvash
Rahman, Durdana
Schmidt, Maria
Hurley, Tara
Grove, Lorna
Richards, Thomas
Koh, Dow-Mu
Nutting, Christopher
Harrington, Kevin
Newbold, Kate
Bhide, Shreerang
Blood transfusion during radical chemo-radiotherapy does not reduce tumour hypoxia in squamous cell cancer of the head and neck
title Blood transfusion during radical chemo-radiotherapy does not reduce tumour hypoxia in squamous cell cancer of the head and neck
title_full Blood transfusion during radical chemo-radiotherapy does not reduce tumour hypoxia in squamous cell cancer of the head and neck
title_fullStr Blood transfusion during radical chemo-radiotherapy does not reduce tumour hypoxia in squamous cell cancer of the head and neck
title_full_unstemmed Blood transfusion during radical chemo-radiotherapy does not reduce tumour hypoxia in squamous cell cancer of the head and neck
title_short Blood transfusion during radical chemo-radiotherapy does not reduce tumour hypoxia in squamous cell cancer of the head and neck
title_sort blood transfusion during radical chemo-radiotherapy does not reduce tumour hypoxia in squamous cell cancer of the head and neck
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5220150/
https://www.ncbi.nlm.nih.gov/pubmed/27884018
http://dx.doi.org/10.1038/bjc.2016.386
work_keys_str_mv AT welshliam bloodtransfusionduringradicalchemoradiotherapydoesnotreducetumourhypoxiainsquamouscellcanceroftheheadandneck
AT panekrafal bloodtransfusionduringradicalchemoradiotherapydoesnotreducetumourhypoxiainsquamouscellcanceroftheheadandneck
AT riddellangela bloodtransfusionduringradicalchemoradiotherapydoesnotreducetumourhypoxiainsquamouscellcanceroftheheadandneck
AT wongkee bloodtransfusionduringradicalchemoradiotherapydoesnotreducetumourhypoxiainsquamouscellcanceroftheheadandneck
AT leachmartino bloodtransfusionduringradicalchemoradiotherapydoesnotreducetumourhypoxiainsquamouscellcanceroftheheadandneck
AT tavassolimahvash bloodtransfusionduringradicalchemoradiotherapydoesnotreducetumourhypoxiainsquamouscellcanceroftheheadandneck
AT rahmandurdana bloodtransfusionduringradicalchemoradiotherapydoesnotreducetumourhypoxiainsquamouscellcanceroftheheadandneck
AT schmidtmaria bloodtransfusionduringradicalchemoradiotherapydoesnotreducetumourhypoxiainsquamouscellcanceroftheheadandneck
AT hurleytara bloodtransfusionduringradicalchemoradiotherapydoesnotreducetumourhypoxiainsquamouscellcanceroftheheadandneck
AT grovelorna bloodtransfusionduringradicalchemoradiotherapydoesnotreducetumourhypoxiainsquamouscellcanceroftheheadandneck
AT richardsthomas bloodtransfusionduringradicalchemoradiotherapydoesnotreducetumourhypoxiainsquamouscellcanceroftheheadandneck
AT kohdowmu bloodtransfusionduringradicalchemoradiotherapydoesnotreducetumourhypoxiainsquamouscellcanceroftheheadandneck
AT nuttingchristopher bloodtransfusionduringradicalchemoradiotherapydoesnotreducetumourhypoxiainsquamouscellcanceroftheheadandneck
AT harringtonkevin bloodtransfusionduringradicalchemoradiotherapydoesnotreducetumourhypoxiainsquamouscellcanceroftheheadandneck
AT newboldkate bloodtransfusionduringradicalchemoradiotherapydoesnotreducetumourhypoxiainsquamouscellcanceroftheheadandneck
AT bhideshreerang bloodtransfusionduringradicalchemoradiotherapydoesnotreducetumourhypoxiainsquamouscellcanceroftheheadandneck